Back to video list Back to Home The Evolution of Pharmacological Treatments and Treatment Goals in MDD and Anxiety You may also like Schizophrenia Congress highlights Article New insights into the pathophysiology and clinical manifestations of schizophrenia Parkinson's Disease Article Ethics in movement disorders – what the clinician needs to know Schizophrenia Article Taper or maintain antipsychotics in schizophrenia? Schizophrenia Article Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden